ClinicalTrials.gg
CompletedNCT03416738Updated Apr 28, 2022

Modeling Treated Recovery From Aphasia

An interventional study of Semantically focused treatment and Phonologically focused treatment in Aphasia, Stroke and Stroke, Ischemic, sponsored by University of South Carolina. Completed at 2 sites in United States. Open to participants aged 21 Years to 80 Years. Per ClinicalTrials.gov, last updated 2022-04-28.

Primary conditionAphasia, BrocaRegistry: AphasiaReclassifiedWhy we changed it
Registry
Aphasia — the first condition term the registry derived for this study.
ClinicalTrials.gg
Aphasia, Broca
Why
  1. The study's listed conditions name Aphasia, Broca, a narrower term within Aphasia.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of South Carolina · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 5 months after the study started (first participant enrolled Aug 2016, registered Jan 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
127
Allocation
Randomized
Ages
21 Years to 80 Years
Sex
All
01

Study summary

Stroke is the leading cause of adult disability in the United States, and aphasia is common following a stroke to the left hemisphere of the brain. Aphasia therapy can improve aphasia recover; however, very little is known about how different patients respond to different types of treatments.

The purpose of this study is to understand how the following factors influence an individual's response to aphasia treatment: 1) biographical factors (e.g., age, education, gender), 2) post-stroke cognitive/linguistic abilities and learning potential, and 3) the location and extent of post-stroke brain damage. We are also interested in understanding the kinds of treatment materials that should be emphasized in speech/language treatment.

Overall, the goal of the current research is to inform the clinical management of post-stroke aphasia by identifying factors that can predict how an individual will respond to different treatment methods.

02

Conditions studied

  • Aphasia
  • Stroke
  • Stroke, Ischemic
  • Aphasia, Broca
  • Aphasia, Global
  • Aphasia, Mixed
  • Aphasia, Jargon
  • Aphasia, Expressive
  • Aphasia, Conduction
  • Aphasia, Fluent
  • Aphasia, Anomic

Browse trials for

03

In context

Aphasia, Broca Reclassified

35 studies on the registry are indexed under Aphasia, Broca; 11 are open to participants now.

This study's enrollment of 127 is above the median of 36 across 33 interventional studies indexed under Aphasia, Broca.

Browse Aphasia, Broca studies →

Lead sponsor

University of South Carolina is the lead sponsor of 197 studies on the registry; 42 are open to participants now.

Compared within Aphasia, Broca, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Aphasia. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
21 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Experienced a left hemisphere ischemic or hemorrhagic stroke At least 12 months post-stroke
  • Primarily English speaker for the past 20 years
  • Ability to provide informed written or verbal consent MRI-compatible (e.g., no metal implants, not claustrophobic)

Exclusion criteria

Exclusion Criteria:

  • History of a right hemisphere stroke (Bilateral stroke)
  • Clinically reported history of dementia, alcohol abuse, psychiatric disorder, traumatic brain injury, or extensive visual acuity or visual-spatial problems
  • Severely limited speech production and/or auditory comprehension that interferes with adequate participation in the therapy provided
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
127 participants (actual)

Study arms

  • Active comparator
    Semantically focused treatment

    This treatment will focus on improving word finding and comprehension of information.

    Behavioral: Semantically focused treatment

  • Active comparator
    Phonologically focused treatment

    This treatment will focus on training speech sound production, targeting overall production abilities.

    Behavioral: Phonologically focused treatment

Interventions

  • BehavioralSemantically focused treatment

    Tasks are as follows: 1. Semantic feature analysis (SFA): For each pictured stimulus the patient is prompted to name the picture, and then to produce related words that represent features similar to the target word. 2. Semantic barrier task: The goal is for one participant (e.g., patient) to describe each card so that the other participant (e.g., clinician) can guess the picture on the card. Participants are only allowed to describe the semantic features of the target and the clinician models the kinds of cues that are allowed. 3. Verb network strengthening treatment (VNeST): This treatment targets lexical retrieval of verbs and their thematic nouns. The objective of VNeST is for the patient to generate verb-noun associates with the purpose of strengthening the connections between the verb and its uses. These are tasks used in clinical aphasia rehabilitation.

  • BehavioralPhonologically focused treatment

    Tasks are as follows: 1. Phonological (sound) components analysis task: Participants are to name a given picture and then to identify the sound features of the target words (e.g., first sound, last sound, and rhyme). 2. Phonological production task: This tasks asks participants to sort and identify the sounds that make up a word. Various stages include identifying first sounds, last sounds, etc. Participants also work on blending sounds together to form words. 3. The phonological judgment task: A computerized presentation of verbs and nouns where participants are required to judge whether pairs of words include similar phonological features. These are tasks used in clinical aphasia rehabilitation.

06

What researchers measure

Primary outcomes

  1. Philadelphia Naming Test

    Assesses the ability to name functional objects

    Time frame: 6 months

07

Study locations

2 sites
  • Medical University of South Carolina
    Charleston, South Carolina 29425, United States
  • University of South Carolina
    Columbia, South Carolina 29208, United States
08

References and documents

Related links

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2016 to primary completion in May 2021, 57 months.

Of 18 interventional studies with no phase under Aphasia, Broca, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 57. This study's 57 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 23, 2018
First posted
Jan 31, 2018
StartActual
Aug 2, 2016
Primary completionActual
May 30, 2021
CompletionActual
May 30, 2021
Last update
Apr 28, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 28, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03416738
Responsible party
Julius Fridriksson (Endowed Professor, University of South Carolina) — Principal investigator
First posted
Jan 31, 2018
Start date
Aug 2, 2016
Primary completion
May 30, 2021
Completion
May 30, 2021
Last update
Apr 28, 2022

Study contacts

Julius Fridriksson, PhD, CCC-SLP
principal investigator · University of South Carolina

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion